Literature DB >> 18793586

Rifampicin, ethambutol and pyrazinamide-induced thrombocytopenia.

S Kant1, N K Natu, V Mahajan.   

Abstract

Drug-induced thrombocytopenia is an uncommon but serious side effect of many drugs including antituberculosis drugs. It is difficult to diagnose but easy to prevent just by stopping the exposure to the same drug again. In some cases, it can prove fatal if not taken care of urgently. Here, we report a case of thrombocytopenia due to rifampicin, ethambutol and pyrazinamide all in an adult male, which we believe is the first to be reported.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793586     DOI: 10.5414/cpp46440

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  4 in total

1.  Gene expression and histopathological evaluation of thiamine pyrophosphate on optic neuropathy induced with ethambutol in rats.

Authors:  Emine Cinici; Nihal Cetin; Bahadir Suleyman; Durdu Altuner; Oguzhan Yarali; Hilal Balta; Ilknur Calik; Levent Tumkaya; Halis Suleyman
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

2.  Pyrazinamide induced thrombocytopenia.

Authors:  Surya Kant; Sanjay Kumar Verma; Vaibhav Gupta; Sunish C Anand; Rajendra Prasad
Journal:  Indian J Pharmacol       Date:  2010-04       Impact factor: 1.200

3.  Thrombocytopenia in HIV patients coinfected with tuberculosis.

Authors:  A S Sandhya; Brijesh Prajapat
Journal:  J Family Med Prim Care       Date:  2017 Oct-Dec

4.  Immune thrombocytopenic purpura in a case of tubercular pleural effusion: A rare presentation.

Authors:  Souren Pal; Nirendra Mohan Biswas; Saikat Dutta; Ramkrishna Brahmachari
Journal:  Lung India       Date:  2016 Jan-Feb
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.